Analysis of new drug registration and review in China in 2021
Analysis of new drug registration and review in China in 2021作者机构：Pharmcube(Beijing)Co.Ltd.Beijing 100020China
出 版 物：《Acta Pharmaceutica Sinica B》 (药学学报（英文版）)
年 卷 期：2022年第12卷第4期
页 面：2127-2128页
核心收录：
学科分类：1007[医学-药学(可授医学、理学学位)] 10[医学]
主 题：investment return industry
摘 要：In recent years,China s pharmaceutical industry has undergone tremendous *** reform of pharmaceutical policies has led to a shift in the direction of drug research and development from generic to innovative,and the sustainable investment from the capital market into the pharmaceutical industry and the return of overseas pharmaceutical talents have together created a boom in drug research and development in China today.
维普期刊数据库
同方期刊数据库